Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:50 UTC |
---|
Update Date | 2022-03-07 02:51:44 UTC |
---|
HMDB ID | HMDB0014766 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Clorazepate |
---|
Description | Clorazepate is only found in individuals that have used or taken this drug. It is a water-soluble benzodiazepine derivative effective in the treatment of anxiety. It has also muscle relaxant and anticonvulsant actions. [PubChem]Benzodiazepines bind nonspecifically to benzodiazepine receptors BNZ1, which mediates sleep, and BNZ2, which affects affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABAA) receptors, this enhances the effects of GABA by increasing GABA affinity for the GABA receptor. Binding of the inhibitory neurotransmitter GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell. |
---|
Structure | OC(=O)C1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2 InChI=1S/C16H11ClN2O3/c17-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)19-14(16(21)22)15(20)18-12/h1-8,14H,(H,18,20)(H,21,22) |
---|
Synonyms | Value | Source |
---|
7-Chloro-2,3-dihydro-2,2-dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid | ChEBI | Clorazepate | ChEBI | 7-Chloro-2,3-dihydro-2,2-dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylate | Generator | Chlorazepate | MeSH | Clorazepate dipotassium | MeSH | Clorazepate monopotassium | MeSH | Dipotassium chlorazepate | MeSH | Tranxene | MeSH | Tranxilium | MeSH | Clorazepic acid | Generator, KEGG | Dipotassium, clorazepate | MeSH, HMDB | Monopotassium, clorazepate | MeSH, HMDB | Chlorazepate, dipotassium | MeSH, HMDB |
|
---|
Chemical Formula | C16H11ClN2O3 |
---|
Average Molecular Weight | 314.723 |
---|
Monoisotopic Molecular Weight | 314.045819935 |
---|
IUPAC Name | 7-chloro-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepine-3-carboxylic acid |
---|
Traditional Name | clorazepate |
---|
CAS Registry Number | 23887-31-2 |
---|
SMILES | OC(=O)C1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2 |
---|
InChI Identifier | InChI=1S/C16H11ClN2O3/c17-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)19-14(16(21)22)15(20)18-12/h1-8,14H,(H,18,20)(H,21,22) |
---|
InChI Key | XDDJGVMJFWAHJX-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as 1,4-benzodiazepines. These are organic compounds containing a benzene ring fused to a 1,4-azepine. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Benzodiazepines |
---|
Sub Class | 1,4-benzodiazepines |
---|
Direct Parent | 1,4-benzodiazepines |
---|
Alternative Parents | |
---|
Substituents | - 1,4-benzodiazepine
- Alpha-amino acid or derivatives
- Aryl chloride
- Aryl halide
- Monocyclic benzene moiety
- Benzenoid
- 1,3-dicarbonyl compound
- Carboxamide group
- Ketimine
- Lactam
- Secondary carboxylic acid amide
- Carboxylic acid derivative
- Carboxylic acid
- Azacycle
- Organic 1,3-dipolar compound
- Monocarboxylic acid or derivatives
- Propargyl-type 1,3-dipolar organic compound
- Organopnictogen compound
- Organic oxygen compound
- Imine
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Organohalogen compound
- Organochloride
- Organonitrogen compound
- Organooxygen compound
- Carbonyl group
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.025 g/L | Not Available | LogP | 3 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Clorazepate,1TMS,isomer #1 | C[Si](C)(C)OC(=O)C1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2NC1=O | 2747.3 | Semi standard non polar | 33892256 | Clorazepate,1TMS,isomer #2 | C[Si](C)(C)N1C(=O)C(C(=O)O)N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C21 | 2537.5 | Semi standard non polar | 33892256 | Clorazepate,2TMS,isomer #1 | C[Si](C)(C)OC(=O)C1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2N([Si](C)(C)C)C1=O | 2549.5 | Semi standard non polar | 33892256 | Clorazepate,2TMS,isomer #1 | C[Si](C)(C)OC(=O)C1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2N([Si](C)(C)C)C1=O | 2653.3 | Standard non polar | 33892256 | Clorazepate,2TMS,isomer #1 | C[Si](C)(C)OC(=O)C1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2N([Si](C)(C)C)C1=O | 3608.9 | Standard polar | 33892256 | Clorazepate,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2NC1=O | 2947.5 | Semi standard non polar | 33892256 | Clorazepate,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C(=O)C(C(=O)O)N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C21 | 2837.6 | Semi standard non polar | 33892256 | Clorazepate,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2N([Si](C)(C)C(C)(C)C)C1=O | 2989.4 | Semi standard non polar | 33892256 | Clorazepate,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2N([Si](C)(C)C(C)(C)C)C1=O | 3061.2 | Standard non polar | 33892256 | Clorazepate,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2N([Si](C)(C)C(C)(C)C)C1=O | 3720.0 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Clorazepate GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-2090000000-36dc0db4681a42cb62d1 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Clorazepate GC-MS (1 TMS) - 70eV, Positive | splash10-00xr-9153000000-20955633c43ee4b5fcf3 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Clorazepate GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Clorazepate GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Clorazepate GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Clorazepate GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Clorazepate GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clorazepate 10V, Positive-QTOF | splash10-014i-0039000000-04f8ade5dbb98231f6d5 | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clorazepate 20V, Positive-QTOF | splash10-014i-0194000000-77f2c863a9b5ed450724 | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clorazepate 40V, Positive-QTOF | splash10-0w4r-3390000000-08793ab9fa2d5c97ebe8 | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clorazepate 10V, Negative-QTOF | splash10-03xr-0089000000-f7743c0f914c2fc65685 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clorazepate 20V, Negative-QTOF | splash10-014i-1092000000-a7f9ddb60f21ad0d8c34 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clorazepate 40V, Negative-QTOF | splash10-0006-9010000000-4ba3a72ff61da2cab011 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clorazepate 10V, Positive-QTOF | splash10-014i-0009000000-3b6dc9550f10c7fb899e | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clorazepate 20V, Positive-QTOF | splash10-00kb-0095000000-26882b3fd53c73fd3908 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clorazepate 40V, Positive-QTOF | splash10-03di-0090000000-4b8c3ab746b6ade0d1f6 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clorazepate 10V, Negative-QTOF | splash10-03di-0009000000-4c893c51087ae5eb95c9 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clorazepate 20V, Negative-QTOF | splash10-014i-2090000000-16b08349edcd85152d86 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clorazepate 40V, Negative-QTOF | splash10-001l-9000000000-071a2b32b700b46350ad | 2021-10-11 | Wishart Lab | View Spectrum |
|
---|